Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GLYCOMIMETICS INC | 153,707 | reported | 15 Dec 2025 | tx 4+276,372 |
| Dyne Therapeutics, Inc. | 132,411 | reported | 19 Aug 2024 | tx 66+637,699−438,979 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Dec 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 19,507 | — | |
| 15 Dec 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 6,000 | — | |
| 15 Dec 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 78,029 | 0.00 USD | deriv |
| 08 Dec 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 172,836 | 0.00 USD | deriv |
| 19 Aug 2024 | SALE | Dyne Therapeutics, Inc. | 305 | 46.00 USD | |
| 19 Aug 2024 | SALE | Dyne Therapeutics, Inc. | 2,400 | 45.01 USD | |
| 11 Jun 2024 | SALE | Dyne Therapeutics, Inc. | 1,823 | 31.34 USD | |
| 16 May 2024 | SALE | Dyne Therapeutics, Inc. | 495 | 28.59 USD | |
| 16 May 2024 | SALE | Dyne Therapeutics, Inc. | 2,279 | 28.20 USD | |
| 11 Jul 2023 | GRANT_AWARD | Dyne Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 11 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 1,776 | 25.71 USD | |
| 11 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 17,825 | 25.48 USD | |
| 11 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 17,825 | 5.54 USD | |
| 08 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 689 | 27.31 USD | |
| 08 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 34,663 | 25.46 USD | |
| 08 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 3,841 | 5.54 USD | |
| 08 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 86,159 | 5.54 USD | |
| 08 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 54,648 | 26.72 USD | |
| 11 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 17,825 | 0.00 USD | deriv |
| 08 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 86,159 | 0.00 USD | deriv |
| 08 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 3,841 | 0.00 USD | deriv |
| 07 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 2,434 | 25.85 USD | |
| 29 Feb 2024 | EXERCISE | Dyne Therapeutics, Inc. | 4,268 | 0.73 USD | |
| 29 Feb 2024 | SALE | Dyne Therapeutics, Inc. | 4,268 | 27.50 USD | |
| 01 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 24,260 | 0.73 USD |